First in Human, Randomized, Blinded, Placebo-Controlled Single Ascending Dose Study of MAR002 in Healthy Men
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Maximum Age: 40
Healthy Volunteers: t
View:
• Willingness to provide written informed consent
• Age 18 to 40
• Weight 55 to 95 kg
• Body mass index (BMI) 18 to 30 kg/m2
• Healthy men
Locations
United States
Arizona
Marea Site
RECRUITING
Tempe
Contact Information
Primary
Andrew Lane
mar-201-info@mareatx.com
415-766-3610
Time Frame
Start Date: 2025-08-11
Estimated Completion Date: 2026-05
Participants
Target number of participants: 37
Treatments
Experimental: Dose A MAR002
Subcutaneous injection
Experimental: Dose B MAR002
Cohort 2 receiving single Dose B
Experimental: Dose C MAR002
Cohort 3 receiving single Dose C
Experimental: Dose D MAR002
Cohort 4 receiving single Dose D
Experimental: Dose E MAR002
Cohort 5 receiving single Dose E
Related Therapeutic Areas
Sponsors
Leads: Marea Therapeutics